202 related articles for article (PubMed ID: 28335045)
1. [Imaging of Metastastic Renal Cell Carcinoma under Therapy with Immune Checkpoint Inhibitors].
Notohamiprodjo M; Kopp HG; Bedke J
Rofo; 2017 Apr; 189(4):287-292. PubMed ID: 28335045
[No Abstract] [Full Text] [Related]
2. Checkpoint inhibitors in bladder and renal cancers: results and perspectives.
Aoun F; Kourie HR; Sideris S; Roumeguère T; van Velthoven R; Gil T
Immunotherapy; 2015; 7(12):1259-71. PubMed ID: 26595284
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics.
Bailey A; McDermott DF
Cancer J; 2013; 19(4):348-52. PubMed ID: 23867517
[TBL] [Abstract][Full Text] [Related]
4. The 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.
Buti S; Bersanelli M
Future Oncol; 2016 Sep; 12(18):2061-3. PubMed ID: 27168416
[No Abstract] [Full Text] [Related]
5. [Immunotherapy of renal cell cancer].
Géczi L; Nagyiványi K; Maráz A
Magy Onkol; 2017 Jun; 61(2):126-131. PubMed ID: 28585613
[TBL] [Abstract][Full Text] [Related]
6. What advances have been made in immune-therapy for renal cell carcinoma?
Verzoni E; Grassi P; Ratta R
Future Oncol; 2017 Apr; 13(8):665-668. PubMed ID: 28183189
[No Abstract] [Full Text] [Related]
7. Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma.
de Velasco G; Krajewski KM; Albiges L; Awad MM; Bellmunt J; Hodi FS; Choueiri TK
Cancer Immunol Res; 2016 Jan; 4(1):12-7. PubMed ID: 26589768
[TBL] [Abstract][Full Text] [Related]
8. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma.
Grünwald V
Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma origin.
Kattan J; Rassy EE; Assi T; Bakouny Z; Pavlidis N
Crit Rev Oncol Hematol; 2018 Oct; 130():60-69. PubMed ID: 30196913
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint blockade immunotherapy for cancer comes of age.
Brower V
J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25745014
[No Abstract] [Full Text] [Related]
11. [Not Available].
Rupp NJ; Mischo A; Moch H
Ther Umsch; 2017 Sep; 74(4):171-179. PubMed ID: 28950771
[No Abstract] [Full Text] [Related]
12. Emerging therapeutic approaches in renal cell carcinoma.
Parekh H; Rini BI
Expert Rev Anticancer Ther; 2015; 15(11):1305-14. PubMed ID: 26376584
[TBL] [Abstract][Full Text] [Related]
13. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features.
Geynisman DM
Eur Urol; 2015 Nov; 68(5):912-4. PubMed ID: 26194044
[No Abstract] [Full Text] [Related]
14. Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma.
Sinnamon AJ; Neuwirth MG; Gimotty PA; Gangadhar TC; Amaravadi RK; Schuchter LM; Karakousis GC
JAMA Oncol; 2018 Jan; 4(1):126-128. PubMed ID: 29145547
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy in lung cancer: New concepts].
Goubet AG; Livartowski A; Romano E
Rev Mal Respir; 2018 Jun; 35(6):642-651. PubMed ID: 29941206
[TBL] [Abstract][Full Text] [Related]
16. Is tumor response important for renal carcinoma?
Inman BA; George DJ
Eur Urol; 2011 Jan; 59(1):16-7. PubMed ID: 20970245
[No Abstract] [Full Text] [Related]
17. T-cell checkpoint inhibitors in metastatic renal cell carcinoma.
Grünwald V
Curr Opin Urol; 2015 Sep; 25(5):411-5. PubMed ID: 26125506
[TBL] [Abstract][Full Text] [Related]
18. Radiomics can predict tumour response in patients treated with Nivolumab for a metastatic renal cell carcinoma: an artificial intelligence concept.
Khene ZE; Mathieu R; Peyronnet B; Kokorian R; Gasmi A; Khene F; Rioux-Leclercq N; Kammerer-Jacquet SF; Shariat S; Laguerre B; Bensalah K
World J Urol; 2021 Sep; 39(9):3707-3709. PubMed ID: 32632555
[No Abstract] [Full Text] [Related]
19. Immune Check Point Inhibition in Sarcomatoid Renal Cell Carcinoma: A New Treatment Paradigm.
Raychaudhuri R; Riese MJ; Bylow K; Burfeind J; Mackinnon AC; Tolat PP; Iczkowski KA; Kilari D
Clin Genitourin Cancer; 2017 Oct; 15(5):e897-e901. PubMed ID: 28645484
[No Abstract] [Full Text] [Related]
20. Immune Checkpoint Therapy in Renal Cell Carcinoma.
Lee CH; Motzer RJ
Cancer J; 2016; 22(2):92-5. PubMed ID: 27111903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
